deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT01560312

Renal Denervation in Refractory Hypertension (PRAGUE-15)

Renal Denervation - Hope for Patients With Refractory Hypertension?

Sponsor: Cardiocenter Podlesí, Trinec, Czech Republic

Conditions Hypertension Resistant to Conventional Therapy
Interventions Renal denervation (Symplicity® Catheter System™)
Updated 11 times since 2017 Last updated: Jan 30, 2019 Started: Oct 31, 2011 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Based on analysis of our data after the Symplicity-3 trial announcement, decision for study termination was done.

Other Hypertension trials with similar outcome

Browse all Hypertension trials

This PHASE3 trial investigates Hypertension and Resistant to Conventional Therapy and is currently terminated or withdrawn. Cardiocenter Podlesí, Trinec, Czech Republic leads this study, which shows 11 recorded versions since 2011 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotTerminated~Aug 2017 – ~May 2018 · 9 months · monthly snapshotTerminated~May 2018 – ~Jun 2018 · 31 days · monthly snapshotTerminated~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotTerminated~Mar 2019 – ~Nov 2020 · 20 months · monthly snapshotTerminated~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE3

▶ Show 6 earlier versions

  1. Nov 2020 — Jan 2021 [monthly]

    Terminated PHASE3

  2. Mar 2019 — Nov 2020 [monthly]

    Terminated PHASE3

  3. Jun 2018 — Mar 2019 [monthly]

    Terminated PHASE3

  4. May 2018 — Jun 2018 [monthly]

    Terminated PHASE3

  5. Aug 2017 — May 2018 [monthly]

    Terminated PHASE3

  6. Jan 2017 — Aug 2017 [monthly]

    Terminated PHASE3

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cardiocenter Podlesí, Trinec, Czech Republic
  • Charles University, Czech Republic
  • General University Hospital, Prague
  • University Hospital Olomouc
Data source: Charles University, Czech Republic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations